Latest News and Press Releases

Planegg/Martinsried, September 18, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...

Medigene is building a broad KRAS library consisting of multiple T cell receptors (TCRs) targeting multiple KRAS mutations and multiple HLAs, covering large patient populations suffering from...

VAXIMM technology enables fast generation and delivery of personalized T-cell cancer vaccines and may overcome key issues faced by the neoantigen fieldNEC OncoImmunity to initiate first clinical trial...

New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Neoantigens Market: Key InsightsAccording to our new research study on “Neoantigens Market to 2028 – Global Analysis and Forecast – by Treatment and...

스위스 바젤/독일 만하임, May 27, 2021 (GLOBE NEWSWIRE) -- 스위스/독일 바이오테크 회사인 VAXIMM AG가 다수의 해외 과학 및 산업 이벤트 참석 계획을 발표했다. 자사는 환자의 세포독성 T세포 활성화를 통해 다양한 암 관련 항원을 표적으로 하는 경구용 플러그 앤 플레이(plug and play) DNA 백신 투여 기술...

BASEL, Switzerland and MANNHEIM, Germany, May 27, 2021 (GLOBE NEWSWIRE) -- VAXIMM AG, a Swiss/German biotech company focused on developing an oral plug and play DNA vaccination technology to...

Fargo, ND, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aldevron has added GMP gene synthesis to its array of services. This expanded capability will be used primarily to support Aldevron’s clients who require...

   Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma Second CTA approval in 2019 – the first was for a NSCLC study Stevenage, UK  13 February...